Virtu Financial LLC Cyclacel Pharmaceuticals, Inc. Transaction History

Virtu Financial LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 15, 2023	BUY	$0.54 - $21.75 $12,848 - $517,497	23,793 New	23,793 $16,000
Q2 2022 Aug 09, 2022	BUY	$6.1 - $7.15 $186,757 - $218,904	30,616 New	30,616 $33,000
Q4 2021 Feb 17, 2022	SELL	$6.04 - $8.03 $120,975 - $160,832	-20,029 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$8.02 - $11.0 $160,632 - $220,319	20,029 New	20,029 $106,000
Q2 2021 Sep 17, 2021	SELL	$7.59 - $10.48 $99,489 - $137,371	-13,108 Closed	0 $0
Q1 2021 May 19, 2021	BUY	$6.86 - $9.24 $19,310 - $26,010	2,815 Added 27.35%	13,108 $93,000
Q4 2020 Feb 24, 2021	BUY	$5.0 - $7.5 $51,465 - $77,197	10,293 New	10,293 $80,000

Ticker CYCC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,539,200
Market Cap $6.02M
Description
Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors, as well as in combin...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.